Akmerkez E3 Blok Kat 7 34335 Etiler stanbul Trkiye Tel: 0 212 385 40 40 retim Yeri: Novo Nordisk A/S Novo All DK-2880 Bagsvrd, Danimarka
Considering that OSAS patients often present with multiple comorbiditiessuch as hypertension, coronary artery disease, and diabetesfurther large-scale, long-term follow-up studies are needed to clarify tirzepatides safety in multimorbid populations (63, 64)
People managing type 2 diabetes who are considering this combination should be especially careful and work closely with their prescribing physician
This has a broader population health benefit as greater access to these medicines will reduce the crippling strain obesity-related conditions have on NHS resources. In the UK, generic competition typically reduces prices paid by the NHS by as much as 80% to 90% after loss of exclusivity, according to the BGMA
Kaptiza C, Nosek L, Jensen L, Hartvig H, Jensen CB, Flint A